Dole to Promote Irvine Firm’s Medical Procedure
Endocare Inc., an Irvine medical-device maker, has lined up former U.S. Sen. Bob Dole to promote its minimally invasive procedure for treating prostate cancer. The company is seeking Medicare approval to cover the $18,000 procedure, which freezes and kills tumors. Dole, treated for prostate cancer in 1991, has been an outspoken champion of early detection. He agreed to join Endocare’s board as an “honorary” member. The company didn’t reveal his compensation but said it would match other directors’.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
